DrugPatentWatch Database Preview
Patent: 6,147,279
» See Plans and Pricing
Summary for Patent: 6,147,279
Title: | Inhibition of gene expression |
Abstract: | A method of inhibiting gene expression is described. The method, which affects enzymatic activity in a plant. The method includes expressing in a plant, or a cell, a tissue or an organ thereof, a nucleotide sequence wherein the nucleotide sequence codes, partially or completely, for an intron in an antisense orientation; and wherein the nucleotide sequence does not contain a sequence that is antisense to an axon sequence normally associated with the intron. |
Inventor(s): | Poulsen; Peter (Copenhagen, DK) |
Assignee: | Danisco A/S (Copenhagen, DK) |
Application Number: | 08/981,803 |
Patent Claims: | see list of patent claims |
Details for Patent 6,147,279
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | Danisco A/S (Copenhagen, DK) | 2015-07-14 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Danisco A/S (Copenhagen, DK) | 2015-07-14 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Danisco A/S (Copenhagen, DK) | 2015-07-14 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 6,147,279
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9704112 | Start Trial |
New Zealand | 313626 | Start Trial |
Mexico | 9800500 | Start Trial |
Japan | H11509103 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |